The opinion concludes that ‘C(M)IT/MIT & Glutaraldehyde Formulations’ is a single biocidal product within the meaning of Article 3(1), point (r), of Regulation (EU) No 528/2012, that it is eligible for Union authorisation in accordance with Article 42(1) of that Regulation and that, subject to compliance with the draft SPC, it meets the conditions laid down in Article 19(1) of that Regulation.
Recital 5, Regulation (EU) 2025/807
In forcesince 28 Apr 2025